Parry Romberg Syndrome: A Case Report
Journal Title: Journal of Case Reports and Studies - Year 2016, Vol 4, Issue 1
Abstract
Parry-Romberg syndrome is a rare disorder characterized by slowly progressive deterioration of the skin and soft tissues of half of the face. The syndrome presents with characteristic skeletal, dental, and soft tissue changes in the affected half of the face, with or without neurological signs and symptoms. The disfiguring nature of the disease Results in psychological disturbance and communication disorders like speech defects, as also dental anomalies. The present article reports a case of a 14-year-old girl who presented with features of Parry Romberg syndrome.
Authors and Affiliations
Revathy V
Keywords
Related Articles
- EP ID EP583235
- DOI 10.15744/2348-9820.4.104
- Views 105
- Downloads 0
How Digital and Physical Care Team Interaction Affect Processing Times: A Case Study of Hospitalists
Importance: Hospitalist physicians face increasing pressure to maximize productivity while maintaining high quality of care. Their success, however, depends on the effective exchange of information among a patient’s care...
Prostate Cancer - Double Vision but Solitary Lesion
A 53 year old man with a background of castrate-sensitive prostate cancer on intermittent androgen deprivation therapy (ADT) presented with right sixth nerve palsy secondary to a solitary right petroclival lesion involvi...
Rupture of a Giant Caesarean Scar Endometriosis Nodule - A Case Report and Literature Review
Background: Abdominal wall endometriosis is a rare condition occurring after caesarean section. A small painful nodule or lump near post caesarean scar is the common presentation. Large size endometrial nodules in anteri...
Mycobacterium Chlorophenolicum Isolation in Sirolimus-Associated Pneumonitis
Mycobacterium chlorophenolicum is a nontuberculous mycobacterium that has previously been characterized as nonpathogenic. We describe a 44 year-old patient with a history of deceased donor renal transplant on sirolimus w...
Evaluating the Effect of Oprelvekin on Cardiac Repolarization in Subjects with Chemotherapy-Induced Thrombocytopenia: An Observational Chart Review of a Phase 2 Clinical Trial in Laredo, Texas
This study tested for the cardiac effects of Oprelvekin, recombinant human interleukin-11, a thrombopoietic growth factor, in patients afflicted with chemotherapy-induced thrombocytopenia (platelet count<50,000 cells/ul)...